Opioid use disorder (OUD) continues to carry significant clinical and economic impact across the U.S. healthcare system. Leveraging a large, nationally representative database, this white paper examines differences in OUD-related hospitalizations and treatment patterns across payer types, demographics, and states—illuminating disparities that can inform evidence-based strategies.
In this content, you will learn:
- How real-world data reveal payer-specific differences in hospitalizations and post-discharge treatment for OUD.
- Insights into high-risk periods, including the elevated risk of overdose following an OUD-related hospitalization.
- Key trends from 2021–2024 in opioid prescribing, including decreases among commercially insured patients and increases among Medicaid patients.
- How timely, data-driven insights can guide targeted interventions to improve outcomes and reduce system costs.